Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
Clinical trial NCT05508594 · COMPLETED
Trial details
- NCT number
- NCT05508594
- Sponsor
- Cessatech A/S
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-05
- Primary completion
- 2023-10-05
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.